Short communicationPublished 29 Jul 2020

Brain Disorders 2020: Gut microbiome marks Alzheimers disease

Authors: Elena Paley

Insights in Neurosurgery

Volume 4 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We reported the induction of neurotoxicity and neurodegeneration by tryptophan metabolites that link the metabolic alterations to Alzheimer’s disease (AD). Tryptophan is a product of Shikimate pathway (SP). Human cells lack SP, which is found in human gut bacteria using exclusively SP to produce aromatic amino acids (AAA). The presented study is a first attempt toward gene targeted analysis of human gut microbiota in AD fecal samples. The oligonucleotide primers newly designed for this work target of SP-AAA in environmental bacteria that is associated with the human activity. Using polymerase chain reaction (PCR) we found unique gut bacterial sequence in most AD patients (18 of 20) albeit rarely in controls (1 of 13). Cloning and sequencing AD-associated PCR products (ADPP) enable the identification of Na (+)-transporting NADHu. Biquinone reductase (NQR) in Clostridium sp. The ADPP of unrelated Alzheimer’s disease (AD) patients possess near identical sequences. NQR substrate ubiquinone is a SP product and also a human neuroprotectant

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Insights in Neurosurgery.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInsights in Neurosurgery
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Elena Paley”